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Introduction 
Dermatomyositis (DM) is a multisystem autoimmune 
disorder that can be triggered by exposure to various 
environmental factors such as UV light, medications, 
drug use, infections, and malignancy and can be part 
of an overlap syndrome. The exact reasons for 
susceptibility to develop DM are unknown but there 
could be a genetic predisposition. Classically, DM 
presents with symmetrical proximal muscle 
weakness, and characteristic cutaneous 
manifestations, such as heliotrope rash and Gottron 
papules. Various clinical phenotypes have been 
described and are associated with specific 
autoantibodies [1]. To date, syphilis has only been 
associated with myositis and not with the clinical 
findings that are strikingly specific for DM. We 
present a case of anti-NXP-2-positive DM in the 
setting of an active syphilis infection.  
Case Synopsis 
A 28-year-old man was admitted to the hospital for 
weight loss, rash, anasarca, and generalized body 
pain and weakness. Two months prior to admission, 
he developed a rash that began on his bilateral knees 
that progressed to the arms, neck, chest, abdomen, 
and back. He reported discomfort from “tense” skin 
but denied any itching. During this time, he also 
experienced migrating joint pain in his knees and 
wrists and muscle weakness that was more 
significant proximally than distally. Additionally, he 
reported considerable fatigue, subjective fevers, 
diffuse swelling, and increasing difficulty 
swallowing. 
His history was notable for a diagnosis of syphilis, for 
which he was treated with IM penicillin G benzathine 
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while in prison 10 months prior., He was sexually 
active with one female partner and had previously 
used methamphetamine, cocaine, and marijuana. He 
had no previous or family history of autoimmune 
diseases. 
On physical examination, he exhibited generalized 
muscle weakness that was more prominent in the 
proximal muscles. On skin exam, he was found to 
have violaceous erythema over the eyelids (Figure 
1A), erythematous, hyperpigmented patches with 
superficial erosion on the chest, back, and upper 
shoulders, and erythematous patches over the 
bilateral knees (Gottron sign; Figure 1B), 
metacarpophalangeal joints, and interphalangeal 
joints (Gottron’s papules; Figure 1C). 
A punch biopsy taken from the patient’s chest 
showed sparse perivascular dermatitis with 
increased mucin and focal basement membrane 
thickening on H/E stain (Figure 2A), supporting the 
clinical impression of DM. Colloidal iron staining 
(Figure 2B) and PAS staining (Figure 2C) further 
highlighted the increased mucin and limited 
basement membrane thickening, respectively.  
Magnetic resonance imaging of the musculature of 
the bilateral thighs revealed diffuse bilateral 
myositis, also consistent with DM.  
Additional physical examination findings of moth-
eaten alopecia (Figure 3), mucous patch at the oral 
commissure, diffuse lymphadenopathy, and 
syphilitic penile chancre, along with positive rapid 
plasma reagin (RPR), (1:16) and syphilis IgM/IgG 
raised the possibility of active syphilis despite past 
treatment. His HIV screen was negative. Punch 
biopsies performed on the scalp and abdomen 
showed granulomatous and lymphoplasmacytic 
infiltrate, but stains for spirochetes, bacteria, 
mycobacterial, and fungal pathogens were negative. 
The patient was treated for active late-stage syphilis 
with a single dose of intramuscular penicillin G 2.4 
MU. 
Rheumatological evaluation revealed elevated PR3 
and ESR, along with positive anti-nuclear, anti-
Ro/SSA, dsDNA, chromatin, and Sm/RNP antibodies. 
Serology was negative for myeloperoxidase 3, 
rheumatoid factor, CCP, centromere, Jo-1, Scl-70, 
and anti-La/SSB antibodies. An extended DM panel 
later revealed the presence of anti-NXP2 antibodies. 
Out of concern for syphilitic myositis, prednisone 
was delayed until a muscle biopsy was done. Muscle 
biopsy of the left thigh showed significant 
perifascicular atrophy and predominantly 
perivascular mononuclear inflammatory infiltrates. 
 
Figure 1. Physical examination findings of A) violaceous erythema over the eyelids (heliotrope rash), B) erythematous patches over the 
bilateral knees (Gottron sign), and C) erythematous patches over the metacarpophalangeal and interphalangeal joints (Gottron 
papules). 
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This was more consistent with DM, rather than 
syphilis-induced myositis, so the patient was 
initiated on prednisone, hydroxychloroquine, and 
trimethoprim/sulfamethoxazole for pneumocystis 
pneumonia prophylaxis. 
The patient was discharged after about two weeks in 
the hospital. Ten days after discharge, he noted 
improved dysphagia, muscle strength, and hair 
growth, but continued to have pruritis on his hands, 
scalp, and knees. 
 
Case Discussion 
Dermatomyositis is an auto-immune inflammatory 
myopathy that primarily affects the skin and muscle. 
It is believed that environmental triggers in 
genetically susceptible individuals result in 
circulating autoantibodies that lead to complement 
deposition in the endothelium of blood vessels to 
the skin and muscle. This eventually causes 
inflammation and necrosis of the blood vessels and 
the supplied structures [2]. 
Although there have been cases of syphilitic 
myositis, syphilitic infection has never been 
previously reported as a trigger for dermatomyositis 
[3, 4]. Reported viral triggers of DM include 
coxsackieviruses, parvoviruses, enteroviruses, 
human T-lymphotropic virus (HTLV), and human 
immunodeficiency virus (HIV), [5]. Our patient was 
treated for syphilis while in prison and presented 10 
months later with classic findings of DM, including 
symmetric proximal muscle weakness, heliotrope 
rash, Gottron papules and sign, dysphagia, and 
polyarthralgia [2]. However, given his history of 
syphilis and positive titers, syphilitic myositis was 
considered, and prednisone was held until it was 
ruled out by muscle biopsy. The presence of diffuse 
lymphadenopathy raised the concern of secondary-
to-late stage syphilis versus DM-associated 
malignancy. Importantly, 20-25% of DM cases are 
associated with a coexisting malignancy discovered 
before, during, or after development of symptoms —  
 
Figure 3. Moth-eaten alopecia of the scalp. 
 
Figure 2. Skin, right chest (punch biopsy). A) Sparse perivascular dermatitis with increased mucin and focal basement membrane 
thickening, consistent with dermatomyositis, H&E, 100×. B) Colloidal iron stain highlighting increased mucin, which stains blue, 100×. 
C) Periodic acid-Schiff stain revealing limited basement membrane thickening (black arrows), 400×. 
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most frequently, solid organ malignancies, including 
adenocarcinomas, and lymphomas [2, 6]. In our 
patient, lymph node biopsy was consistent with a 
reactive rather than malignant process, supporting 
the diagnosis of active infection with syphilis. 
Our patient’s rheumatology workup was positive for 
the presence of anti-NXP2, an autoantibody specific 
for dermatomyositis. NXP2 is a nuclear matrix protein 
involved in the regulation of the p53-induced 
cellular apoptosis in response to oncogenic signals 
[1, 7]. Antibodies to NXP2 have been reported in up 
to 30% of cases of juvenile and adult 
dermatomyositis and is associated with distal 
weakness, more severe myalgias, peripheral edema, 
and a higher risk of dysphagia — the latter three of 
which were characteristics observed in our patient 
[8]. Although patients may have classic skin findings 
such as Grotton papules and heliotrope rash, anti-
NXP2-positive DM patients tend to have less severe 
skin manifestations [1]. Other distinct characteristics 
associated with the NXP2 autoantibody include an 
increased risk of calcinosis cutis, which was not 
observed in our patient [1]. 
 
Conclusion 
Autoimmune disease occurs in the setting of a 
complex interplay between environmental, genetic, 
and immune factors. Many environmental factors, 
including ultraviolet light, medications, drug use, 
infections, and malignancy have been reported to 
trigger autoimmune diseases, including 
dermatomyositis, in genetically and 
immunologically susceptible individuals. Several 
infections have been linked to the development of 
dermatomyositis, likely through immune activation, 
including influenza, borrelia, toxoplasmosis, and 
other viral infections. To our knowledge, syphilis has 
never been previously reported as a trigger for 
dermatomyositis. In our patient, it is possible that his 
syphilis infection was the environmental stressor 
that triggered DM in this genetically and 
immunologically susceptible patient, again 
highlighting the complex interplay between internal 
and external factors that drive autoimmune disease. 
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